| Trial Status | Closed for recruitment |
| Dates | Date of activation: 08-Dec-98 Date Step1 close: 04-Aug-08 |
| Data management at EORTC | Full |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Advanced |
| Targeted Sample size | 2000 |
| Number of steps | 3 |
| Drug | Mercaptopurine Tioguanine L-asparaginase Cyclophosphamide Cytarabine Daunorubicin Doxorubicin Etoposide Methotrexate Methylprednisolone Prednisolone Vincristine Vindesine Dexamethasone Pegaspargase |
| Study Staff | Jacques Otten (Study Coordinator) - Universitair Ziekenhuis Brussel, Brussels Stefan Suciu (Statistician) - EORTC Headquarters, Brussels Lies Meirlaen (Data Manager) - EORTC Headquarters, Brussels Séraphine Rossi (Data Manager) - EORTC Headquarters, Brussels Gaetan de Schaetzen (Project Manager) - EORTC Headquarters, Brussels, gaetan.deschaetzen( at )eortc.be, +32 27741618 |
| Type of cancer | Acute Lymphocytic Leukemia Non Hodgkins Lymphoma |
| Participating Groups | EORTC Children's Leukemia Group(Coordinating Group) |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00003728 |
| EudraCT | |
| Protocol documents in PDF (requires password) | Study documentation |